BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1475299)

  • 1. Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze.
    Bartolini L; Risaliti R; Pepeu G
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1161-4. PubMed ID: 1475299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oxiracetam on scopolamine-induced amnesia in the rat in a spatial learning task.
    Pitsikas N; Algeri S
    Pharmacol Biochem Behav; 1992 Nov; 43(3):949-51. PubMed ID: 1448491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of scopolamine and mecamylamine on working and reference memory in the rat.
    Moran PM
    Pharmacol Biochem Behav; 1993 Jul; 45(3):533-8. PubMed ID: 8332613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35,926 (CI-979).
    M'Harzi M; Palou AM; Oberlander C; Barzaghi F
    Pharmacol Biochem Behav; 1995 May; 51(1):119-24. PubMed ID: 7617721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.
    Preda L; Alberoni M; Bressi S; Cattaneo C; Parini J; Canal N; Franceschi M
    Psychopharmacology (Berl); 1993; 110(4):421-6. PubMed ID: 7870912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock.
    Itoh J; Nabeshima T; Kameyama T
    Psychopharmacology (Berl); 1990; 101(1):27-33. PubMed ID: 2343073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions.
    Bartolini L; Casamenti F; Pepeu G
    Pharmacol Biochem Behav; 1996 Feb; 53(2):277-83. PubMed ID: 8808132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats.
    Sakurai T; Ojima H; Yamasaki T; Kojima H; Akashi A
    Jpn J Pharmacol; 1989 May; 50(1):47-53. PubMed ID: 2724699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoidance facilitation by nootropics.
    Sansone M; Oliverio A
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S89-97. PubMed ID: 2616794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scopolamine impairs delayed matching in an olfactory task in rats.
    Ravel N; Vigouroux M; Elaagouby A; Gervais R
    Psychopharmacology (Berl); 1992; 109(4):439-43. PubMed ID: 1365859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of MDMA and scopolamine on working versus reference memory in the radial arm maze task.
    Kay C; Harper DN; Hunt M
    Neurobiol Learn Mem; 2010 Feb; 93(2):151-6. PubMed ID: 19766200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholine.
    Giovannini MG; Spignoli G; Carlà V; Pepeu G
    Pharmacol Res; 1991 Dec; 24(4):395-405. PubMed ID: 1805193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in mice.
    Hlinák Z; Krejcí I
    Behav Brain Res; 2002 Jul; 133(2):395-9. PubMed ID: 12110475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pesticides and drugs on working memory in rats: continuous delayed response.
    Heise GA; Hudson JD
    Pharmacol Biochem Behav; 1985 Oct; 23(4):591-8. PubMed ID: 3934688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats.
    Ballard TM; McAllister KH
    Psychopharmacology (Berl); 1999 Sep; 146(1):10-8. PubMed ID: 10485959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice).
    Petkov VD; Mosharrof AH; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(1):3-13. PubMed ID: 3136617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scopolamine differentially affects memory of 8- and 16-month-old rats in the double Y-maze.
    Biggan SL; Ingles JL; Beninger RJ
    Neurobiol Aging; 1996; 17(1):25-30. PubMed ID: 8786799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the behavioral effects of cognition-enhancing drugs and brain acetylcholine. Nootropic drugs and brain acetylcholine.
    Pepeu G; Spignoli G; Giovannini MG; Magnani M
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():116-9. PubMed ID: 2602443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.